Evidence map›Paper›PMID 36899991›Full record

ArticleDiagnostics (Basel, Switzerland)2023

The Clinical Significance of Salusins in Systemic Sclerosis-A Cross-Sectional Study.

Joanna Nowaczyk, Leszek Blicharz, Michał Zawistowski, Mariusz Sikora, Michał Zaremba, Joanna Czuwara, Lidia Rudnicka

Full text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Biomarkers in Systemic Sclerosis: An Overview.Current issues in molecular biology · 2023
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Joanna NowaczykDepartment of Dermatology, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0001-7438-3559
Leszek BlicharzDepartment of Dermatology, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-7633-4168
Michał ZawistowskiDepartment of Dermatology, Medical University of Warsaw, 02-091 Warsaw, Poland.ORCID 0000-0002-5173-6283
Mariusz SikoraNational Institute of Geriatrics, Rheumatology and Rehabilitation, 02-637 Warsaw, Poland.ORCID 0000-0002-6162-9916
Michał ZarembaDepartment of Dermatology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Joanna CzuwaraDepartment of Dermatology, Medical University of Warsaw, 02-091 Warsaw, Poland.
Lidia RudnickaDepartment of Dermatology, Medical University of Warsaw, 02-091 Warsaw, Poland.

Funding

Medical University of Warsaw 1M4/2/M/MG/N/20
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkersfibrosisinflammationsystemic sclerosisvascular remodelingvasodilatation

Identifiers

PMID36899991
PMCPMC10001236

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read6
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.